药物法庭参与者的艾滋病毒/性传播感染风险行为。
HIV/STI Risk Behavior of Drug Court Participants.
作者信息
Robertson Angela A, St Lawrence Janet S, McCluskey D Lee
机构信息
Social Science Research Center, Mississippi State University, Starkville, Mississippi, USA.
出版信息
J Offender Rehabil. 2012 Jul;51(7):453-473. doi: 10.1080/10509674.2012.702715.
Drug abusing offenders have high rates of HIV and other sexually transmitted infections (STI). To date, the HIV/STI prevention needs of offenders in drug court programs have been ignored. This multi-method study employed interviews to assess drug court professionals' perceptions of the need for an HIV risk reduction intervention to be integrated into the services provided to drug court participants. Then, surveys were completed by 235 drug court participants to assess whether their sexual risk behaviors affirmed the need for such an intervention. The survey also assessed demographic characteristics, drug use prior to program entry, HIV knowledge, and condom attitudes. The relationship between duration in the drug court program and sexual risk behavior was also examined. Implications for the development and delivery of HIV risk reduction interventions within drug court programs are discussed.
药物滥用罪犯感染艾滋病毒和其他性传播感染（STI）的比例很高。迄今为止，药物法庭项目中罪犯的艾滋病毒/性传播感染预防需求一直被忽视。这项多方法研究通过访谈来评估药物法庭专业人员对于将降低艾滋病毒风险干预措施纳入为药物法庭参与者提供的服务中的必要性的看法。然后，235名药物法庭参与者完成了调查，以评估他们的性风险行为是否证实了这种干预措施的必要性。该调查还评估了人口统计学特征、进入项目前的药物使用情况、艾滋病毒知识以及对避孕套的态度。同时也研究了在药物法庭项目中的时长与性风险行为之间的关系。文中讨论了在药物法庭项目中开展和提供降低艾滋病毒风险干预措施的意义。
Zotero 插件